189 related articles for article (PubMed ID: 12630076)
21. [Clinical value of p16
Song FB; Du H; Xiao AM; Wang C; Huang X; Yan PS; Liu ZH; Qu XF; Belinson JEROMEL; Wu RF
Zhonghua Fu Chan Ke Za Zhi; 2020 Nov; 55(11):784-790. PubMed ID: 33228350
[No Abstract] [Full Text] [Related]
22. Accuracy of liquid-based Pap tests: comparison of concurrent liquid-based tests and cervical biopsies on 782 women with previously abnormal Pap smears.
Guo M; Hu L; Martin L; Liu S; Baliga M; Hughson MD
Acta Cytol; 2005; 49(2):132-8. PubMed ID: 15839615
[TBL] [Abstract][Full Text] [Related]
23. Usefulness of liquid-based cytology specimens for the immunocytochemical study of p16 expression and human papillomavirus testing: a comparative study using simultaneously sampled histology materials.
Yoshida T; Fukuda T; Sano T; Kanuma T; Owada N; Nakajima T
Cancer; 2004 Apr; 102(2):100-8. PubMed ID: 15098254
[TBL] [Abstract][Full Text] [Related]
24. Potential influence of p16 immunohistochemical staining on the diagnosis of squamous cell lesions in cervical biopsy specimens: observation from cytologic-histologic correlation.
Yang J; Elliott A; Hoffa AL; Herring N; Houser PM
Cancer Cytopathol; 2018 Dec; 126(12):1003-1010. PubMed ID: 30307707
[TBL] [Abstract][Full Text] [Related]
25. [Association between high risk HPV viral load, p16ink4a expression and intra-epithelial cervical lesions].
Eleutério Junior J; Giraldo PC; Cavalcante DI; Gonçalves AK; Eleutério RM
Rev Assoc Med Bras (1992); 2007; 53(6):530-4. PubMed ID: 18157369
[TBL] [Abstract][Full Text] [Related]
26. Comparative analysis of a liquid-based Pap test and concurrent HPV DNA assay of residual samples. A study of 608 cases.
Hong IS; Marshalleck J; Williams RH; Gaiter TE; Mielzynska-Lohnas I; Kim K
Acta Cytol; 2002; 46(5):828-34. PubMed ID: 12365215
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of the ThinPrep Pap test in clinical practice. A seven-month, 16,314-case experience in northern Vermont.
Papillo JL; Zarka MA; St John TL
Acta Cytol; 1998; 42(1):203-8. PubMed ID: 9479341
[TBL] [Abstract][Full Text] [Related]
28. Using p16 immunohistochemistry to classify morphologic cervical intraepithelial neoplasia 2: correlation of ambiguous staining patterns with HPV subtypes and clinical outcome.
Liu Y; Alqatari M; Sultan K; Ye F; Gao D; Sigel K; Zhang D; Kalir T
Hum Pathol; 2017 Aug; 66():144-151. PubMed ID: 28705710
[TBL] [Abstract][Full Text] [Related]
29. Comparison of p16INK4a and ProEx C immunostaining on cervical ThinPrep cytology and biopsy specimens.
Oberg TN; Kipp BR; Vrana JA; Bartholet MK; Fales CJ; Garcia R; McDonald AN; Rosas BL; Henry MR; Clayton AC
Diagn Cytopathol; 2010 Aug; 38(8):564-72. PubMed ID: 19937941
[TBL] [Abstract][Full Text] [Related]
30. Combined p16INK4a and human papillomavirus testing improves the prediction of cervical intraepithelial neoplasia (CIN II-III) in Thai patients with low-grade cytological abnormalities.
Ekalaksananan T; Pientong C; Kongyingyoes B; Chaiwongkot A; Yuenyao P; Kleebkaow P; Kritpetcharat O; Evans MF
Asian Pac J Cancer Prev; 2011; 12(7):1777-83. PubMed ID: 22126564
[TBL] [Abstract][Full Text] [Related]
31. Eosinophilic dysplasia of the cervix: a newly recognized variant of cervical squamous intraepithelial neoplasia.
Ma L; Fisk JM; Zhang RR; Ulukus EC; Crum CP; Zheng W
Am J Surg Pathol; 2004 Nov; 28(11):1474-84. PubMed ID: 15489651
[TBL] [Abstract][Full Text] [Related]
32. p16(INK4a) immunoprofiles of squamous lesions of the uterine cervix-implications for the reclassification of atypical immature squamous metaplasia.
Skapa P; Robova H; Rob L; Zamecnik J
Pathol Oncol Res; 2013 Oct; 19(4):707-14. PubMed ID: 23686439
[TBL] [Abstract][Full Text] [Related]
33. Utility of p16INK4a expression for the interpretation of uterine cervical biopsies in Kenya.
Muvunyi TZ; Rohner E; O'Connor S; Kalebi AY; Waweru W; Kairu J; Ochuk W; Smith JS; Muchiri LW
Pan Afr Med J; 2021; 40():55. PubMed ID: 34795834
[TBL] [Abstract][Full Text] [Related]
34. The evaluation of p16INK4a immunoexpression/immunostaining and human papillomavirus DNA test in cervical liquid-based cytological samples.
Nasioutziki M; Daniilidis A; Dinas K; Kyrgiou M; Valasoulis G; Loufopoulos PD; Paraskevaidis E; Loufopoulos A; Karakitsos P
Int J Gynecol Cancer; 2011 Jan; 21(1):79-85. PubMed ID: 21330832
[TBL] [Abstract][Full Text] [Related]
35. Low-grade squamous intraepithelial lesion/cannot exclude high-grade squamous intraepithelial lesion (LSIL-H) is a unique category of cytologic abnormality associated with distinctive HPV and histopathologic CIN 2+ detection rates.
Barron S; Li Z; Austin RM; Zhao C
Am J Clin Pathol; 2014 Feb; 141(2):239-46. PubMed ID: 24436272
[TBL] [Abstract][Full Text] [Related]
36. p16INK4A in routine practice as a marker of cervical epithelial neoplasia.
Kurshumliu F; Thorns C; Gashi-Luci L
Gynecol Oncol; 2009 Oct; 115(1):127-131. PubMed ID: 19596140
[TBL] [Abstract][Full Text] [Related]
37. Performance of an imaging system vs. manual screening in the detection of squamous intraepithelial lesions of the uterine cervix.
Dziura B; Quinn S; Richard K
Acta Cytol; 2006; 50(3):309-11. PubMed ID: 16780026
[TBL] [Abstract][Full Text] [Related]
38. Cyclin E expression and early cervical neoplasia in ThinPrep specimens. A feasibility study.
Weaver EJ; Kovatich AJ; Bibbo M
Acta Cytol; 2000; 44(3):301-4. PubMed ID: 10833982
[TBL] [Abstract][Full Text] [Related]
39. Protein p16 as a marker of dysplastic and neoplastic alterations in cervical epithelial cells.
Volgareva G; Zavalishina L; Andreeva Y; Frank G; Krutikova E; Golovina D; Bliev A; Spitkovsky D; Ermilova V; Kisseljov F
BMC Cancer; 2004 Aug; 4():58. PubMed ID: 15339339
[TBL] [Abstract][Full Text] [Related]
40. Cell cycle and/or proliferation markers: what is the best method to discriminate cervical high-grade lesions?
Lorenzato M; Caudroy S; Bronner C; Evrard G; Simon M; Durlach A; Birembaut P; Clavel C
Hum Pathol; 2005 Oct; 36(10):1101-7. PubMed ID: 16226110
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
